Drug Master File reporting on 77 active substances needs to be notified from next month

The Korea Food and Drug Administration says that local pharmaceutical firms' drug master file (DMP) reporting of 77 active substances in terms of therapeutic category, which is divided into three groups, will begin from June 21 to the end of August, noting the full DMF application on these substances will be made available from January of next year.

- 24 active substances belonging to the fi...